GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » PS Ratio

Rapid Dose Therapeutics (XCNQ:DOSE) PS Ratio : 20.91 (As of Dec. 15, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Rapid Dose Therapeutics's share price is C$0.23. Rapid Dose Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was C$0.01. Hence, Rapid Dose Therapeutics's PS Ratio for today is 20.91.

The historical rank and industry rank for Rapid Dose Therapeutics's PS Ratio or its related term are showing as below:

XCNQ:DOSE' s PS Ratio Range Over the Past 10 Years
Min: 7.73   Med: 19.5   Max: 350
Current: 20.91

During the past 13 years, Rapid Dose Therapeutics's highest PS Ratio was 350.00. The lowest was 7.73. And the median was 19.50.

XCNQ:DOSE's PS Ratio is ranked worse than
69.46% of 1015 companies
in the Biotechnology industry
Industry Median: 8.69 vs XCNQ:DOSE: 20.91

Rapid Dose Therapeutics's Revenue per Sharefor the three months ended in Aug. 2024 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was C$0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Rapid Dose Therapeutics was 10.00% per year.

During the past 13 years, Rapid Dose Therapeutics's highest 3-Year average Revenue per Share Growth Rate was 91.30% per year. The lowest was 91.30% per year. And the median was 91.30% per year.

Back to Basics: PS Ratio


Rapid Dose Therapeutics PS Ratio Historical Data

The historical data trend for Rapid Dose Therapeutics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics PS Ratio Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 345.00 21.00 15.00 12.86 17.50

Rapid Dose Therapeutics Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 17.78 17.50 22.00 14.09

Competitive Comparison of Rapid Dose Therapeutics's PS Ratio

For the Biotechnology subindustry, Rapid Dose Therapeutics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's PS Ratio falls into.



Rapid Dose Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Rapid Dose Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.23/0.011
=20.91

Rapid Dose Therapeutics's Share Price of today is C$0.23.
Rapid Dose Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Rapid Dose Therapeutics  (XCNQ:DOSE) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Rapid Dose Therapeutics PS Ratio Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines